Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in

Gregory N Ruegsegger1, Shankarappa Manjunatha1, Priska Summer1

  • 1Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA; and.

Insights

Insulin deficiency impairs brain mitochondrial function, impacting ATP production and neuronal health. Intranasal insulin may offer therapeutic benefits for dementia associated with diabetes.

Area of Science:

  • Neuroscience
  • Metabolic disorders
  • Mitochondrial biology

Background:

  • Diabetes is strongly linked to dementia, but the precise mechanisms by which insulin deficiency harms brain function are not fully understood.
  • Mitochondrial dysfunction is implicated in neurodegenerative diseases, including dementia associated with diabetes.

Purpose of the Study:

  • To investigate the impact of insulin deficiency on brain mitochondrial function and explore the therapeutic potential of intranasal insulin.
  • To elucidate the role of insulin in maintaining brain mitochondrial homeostasis and neuronal health.

Main Methods:

  • Streptozotocin-induced diabetic mice were used to model insulin deficiency.
  • Mitochondrial ATP production, enzyme activities (citrate synthase, cytochrome oxidase), mitochondrial fusion/fission proteins, reactive oxygen species (ROS) emission, and proteomic changes were analyzed in brain regions.
  • Intranasal insulin administration was performed in healthy mice to assess its direct effects.

Main Results:

  • Insulin deficiency decreased mitochondrial ATP production and key enzyme activities in the cerebrum, hypothalamus, and hippocampus.
  • Altered mitochondrial dynamics (decreased fusion, increased fission) and increased ROS emission (upon monocarboxylate transporter inhibition) were observed.
  • Intranasal insulin administration in healthy mice boosted mitochondrial ATP production, and proteomics revealed insulin's role in enhancing neuronal development and neurotransmission while mitigating tau phosphorylation.

Conclusions:

  • Insulin is critical for maintaining brain mitochondrial homeostasis and function.
  • Insulin deficiency contributes to mitochondrial dysfunction and neurodegeneration, potentially explaining dementia in diabetes.
  • Intranasal insulin shows promise as a therapeutic strategy for improving brain mitochondrial function and neuronal health.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.9K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.1K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
724
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
762
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.4K